Company intelligence / Profile preview

Iron Horse Diagnostics

Scottsdale/Phoenix, Arizona, United Statesazbio.org ↗

Ownership: Private
Development stage: Commercial

Overview

The company has developed blood and CSF-based diagnostic assays for ALS that have undergone peer-reviewed validation. A multicenter clinical study was conducted to evaluate the sensitivity, specificity, and accuracy of their ALS test. The company also offers advanced biomarker assay services and has expanded into CNS-targeted gene therapies with a novel AAV capsid library.

Therapeutic areas: Neurology
Modalities: Diagnostic assayGene therapyBiomarker assay services
Industry: Biotech

Partnerships

BiogenNIH funding partnersThe ALS AssociationArizona Commerce Authority

Beyond the preview

Go deeper on Iron Horse Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Iron Horse Diagnostics.

Explore the full profile